Inter- and intraobserver variation in HR-CTV contouring: Intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy

Radiotherapy and Oncology

Volumn 89, Issue 2, 2008, Pages 164-171

  Petric, Primoz ^a,b   Dimopoulos, Johannes ^a   Kirisits, Christian ^a   Berger, Daniel ^a   Hudej, Robert ^a,b   Pötter, Richard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Interobserver analysis; MRI based cervix cancer brachytherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT PLANNING; TUMOR VOLUME; UTERINE CERVIX; UTERINE CERVIX CANCER;

BRACHYTHERAPY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; OBSERVER VARIATION; RADIOGRAPHY, INTERVENTIONAL; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 51049099674     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.07.030     Document Type: Article

References (43)

1. Haie-Meder C., Pötter R., Van Limbergen E., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74 (2005) 235-245
2. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 8 (2001) 781-786
3. Morris M., Eifel P.J., Lu J., Grigsby P.W., Levenback C., Stevens R.E., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 40 (1999) 1137-1143
4. Whitney C.W., Sause W., Bundy B.N., Malfetano J.H., Hannigan E.V., Fowler Jr. W.C., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
5. Rose P.G., Bundy B.N., Watkins E.B., Thigpen J.T., Deppe G., Maiman M.A., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
6. Pötter R., Dimopoulos J., Bachtiary B., et al. 3D conformal HDR brachy- and external beam therapy plus simultaneous Cisplatin for high-risk cervical cancer: clinical experience with 3 year follow-up. Radiother Oncol 79 (2006) 80-86
7. Wachter-Gerstner N., Wachter S., Reinstadler E., et al. The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trial. Radiother Oncol 68 (2003) 51-59
8. Wachter-Gerstner N., Wachter S., Reinstadler E., et al. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother Oncol 68 (2003) 269-276
9. Kirisits C., Pötter R., Lang S., et al. Dose and volume parameters for MRI based treatment planning in intracavitary brachytherapy of cervix cancer. Int J Radiat Oncol Biol Phys 62 (2005) 901-911
10. Lindegaard J.C., Tanderup K., Nielsen S.K., Haack S., and Gelineck J. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 71 (2008) 756-764
11. De Brabandere M., Mousa A.G., Nulens A., Swinnen A., and Van Limbergen E. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol 88 (2008) 217-226
12. Dimopoulos J.C.A., Schard G., Berger D., et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, patho-anatomical structures and organs at risk. Int J Radiat Oncol Biol Phys 64 (2006) 1380-1388
13. Shin K., Kim T., Cho J., et al. CT-guided intracavitary radiotherapy for cervical cancer: comparison of conventional point A plan with clinical target volume-based 3-dimensional plan using dose-volume parameters. Int J Radiat Oncol Biol Phys 64 (2006) 197-204
14. Brooks S., Bownes P., Lowe G., Bryant L., and Hoskin P.J. Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading. Int J Radiat Oncol Biol Phys 63 (2005) 934-939
15. Chajon E., Dumas I., Touleimat M., et al. Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer. Int J Radiat Oncol Biol Phys 69 (2007) 955-961
16. Kim R.Y., and Pareek P. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: analysis of dose-volume histograms. Brachytherapy 2 (2003) 200-206
17. Pelloski C.E., Palmer M., Chronowski G.M., Jhingran A., Horton J., and Eifel P.J. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62 (2005) 131-137
18. Kirisits C., Lang S., Dimopoulos J., et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys 65 (2006) 624-630
19. Dimopoulos J.C.A., Kirisits C., Petric P., et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys 66 (2006) 83-90
20. Pötter R., Haie-Mader C., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC-ESTRO Working Group: (II): concepts and terms of 3D imaging, radiation physics, radiobiology, and 3D dose volume parameters. Radiother Oncol 78 (2006) 67-77
21. Viswanathan A.N., Dimopoulos J.C.A., Kirisits C., et al. CT versus MRI-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys 68 (2007) 491-498
22. Pötter R., Dimopoulos J., Georg P., et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 83 (2007) 148-155
23. Saarnak A.E., Boersma M., Van Bunnigen B.N.F.M., et al. Inter-observer variation in delineation of bladder and rectum contours for brachytherapy of cervical cancer. Radiother Onclo 56 (2000) 37-42
24. Wu D.H., Mayr N.A., Karatas Y., et al. Interobserver variation in cervical cancer tumour delineation for image based radiotherapy planning among and within different specialties. J Appl Clin Med Phys 6 (2005) 106-110
25. Weiss E., Richter S., Krauss T., et al. Conformal radiotherapy planning of cervix carcinoma: differences in the delineation of target volume. A comparison between gynaecologic and radiation oncologists. Radiother Oncol 67 (2003) 87-95
26. Weltens C., Menten J., Feron M., et al. Interobserver variation in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging. Radiother Oncol 60 (2001) 49-59
27. Khoo V., Adams E.J., Saran F., et al. A comparison of clinical target volumes determined by CT and MRI for the radiotherapy planning of base of skull meningiomas. Int J Radit Oncol Biol Phys 46 (2000) 1309-1317
28. Rasch C., Barillot I., Remeijer P., et al. Definition of the prostate in CT and MRI: a multiobserver study. Int J Radiat Oncol Biol Phys 43 (1999) 57-66
29. Struikmans H., Warlam-Rodenhuis C., and Stam T. Interobserver variability of clinical target volume delineation of glandular breast tissue and of boost volume in tangential breast irradiation. Radiother Oncol 76 (2005) 293-299
30. Hurkmans C.W., Borger J.H., Pieters B.R., et al. Variability in target volume delineation on CT scans of the breast. Int J Radiat Oncol Biol Phys 50 (2001) 1366-1372
31. Steenbakers R.J.H.M., Duppen J.C., Fitton I., et al. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a big brother evaluation. Radiother Oncol 77 (2005) 182-190
32. Steenbakers R.J.H.M., Duppen J.C., Fitton I., et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three dimensional analysis. Int J Radiat Oncol Biol Phys 64 (2006) 435-448
33. Lang S., Nulens A., Briot E., et al. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother Oncol 78 (2006) 185-193
34. Nulens A, Lang S, Briot E, et al. Evaluation of contouring concepts and dose volume parameters of MR based brachytherapy treatment plans for cervix cancer: results and conclusions of the GEC-ESTRO GYN working group delineation workshops. In: GEC-ESTRO meeting, Budapest; 2005. Radiother Oncol 2005;75:S9.
35. Dimopoulos JCA, De Vos V, Berger D, et al. Interobserver comparison of target delineation in MRI based cervix cancer brachytherapy according to the GYN GEC-ESTRO recommendations. In: GEC-ESTRO-ISIORT Europe joint meeting, Montpellier; 2007. Radiother Oncol 2007;83:18-9.
36. Shiraiwa M., Joja I., et al. Cervical carcinoma: efficacy of thin-section oblique axial T2-weighted images for evaluating parametrial invasion. Abdominal Imaging 24 (1999) 514-519
37. Murakami T., Kurachi H., Nakamura H., et al. Cervical invasion of endometrial carcinoma evaluation by parasagittal MR imaging. Acta Radiol 36 (1995) 248-253
38. Joja I., Asakawa T., et al. Dynamic MR imaging of endometrial carcinoma with turbo-FLASH technique. JCAT 20 (1994) 878-887
39. Gerbaulet A., Pötter R., and Haie-Meder C. Cervix cancer. In: Gerbaulet A., Pötter R., Mazeron J.J., Meertens H., and Van Limbergen E. (Eds). The GEC ESTRO handbook of brachytherapy (2002), European Society of Therapeutic Radiology and Oncology, Brussels 300-363
40. Lee R., Roach M., Michalski J., et al. Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy. Int J Radiat Oncol Biol Phys 54 (2002) 457-461
41. Boss E.A., Barentsz J.O., Masuger L.F.A.G., and Boonstra H. The role of MR imaging in cervical carcinoma. Eur Radiol 10 (2000) 256-270
42. Hricak H., Lacey C.G., Sandles L.G., et al. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology 166 (1988) 623-631
43. Kirisits C., Siebert F.A., Baltas D., et al. Accuracy of volume and DVH parameters determined with different brachytherapy treatment planning systems. Radiother Oncol 84 (2007) 290-297